Deargen vs Standigm
Deargen
AI-First Pharmatech Company. We are exploring sequence-based drug discovery and development
9 employees · est. 2016 · Daejeon, Korea South
Standigm is the older company (2016 vs 2015); Standigm is the larger of the two.
Side-by-Side Comparison
| Metric | Deargen | Standigm |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2015 older |
| Headquarters | ||
| Headquarters | Daejeon, Korea South | Seoul, Korea South |
| Employees | ||
| Employees | 9 | 23 larger |
| Industry | ||
| Industry | AI, Biotechnology, Machine Learning | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Growth |
| Total Funding | ||
| Total Funding | $23.00B | $78.57M |
| Funding Rounds | ||
| Funding Rounds | 3 | 8 |
| Services | ||
| Services | AI Platform for Drug Discovery, New Drug Development, Molecular Optimization, Target Affinity Prediction, Toxicity-Centered Drug Design | AI Drug Discovery, Target Identification, Lead Optimization, AI SaaS & API Solutions, Pipeline Development |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Firms, Medical Research Institutions, Drug Development Organizations, AI-Driven Healthcare Providers | Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Healthcare Providers, Labs looking for AI solutions |
| Taxonomy | ||
| Taxonomy | AI-driven Drug DiscoverySequence-based Drug DevelopmentTransformer Technology In PharmaceuticalsHit/Lead Compound DiscoveryEnd-to-end AI SolutionBiotechnology Innovation +9 | AI-driven Drug DiscoveryWorkflow AutomationMolecular DesignNovel Target IdentificationLead Compound GenerationFirst-in-Class Drug Development +7 |
| Website | ||
| Website | deargen.me | standigm.com |
About Deargen
Deargen, founded in 2016, positions itself as a pioneer in the intersection of AI and pharmaceuticals. This AI-First Pharmatech Company focuses on revolutionizing drug discovery and development through sequence-based AI solutions. Headquartered in Korea South, the company leverages advanced AI, part...
About Standigm
Standigm, founded in 2015, is a Korean-based company specializing in AI-driven drug discovery. With its slogan, "The workflow AI drug discovery company," Standigm leverages cutting-edge proprietary AI platforms to revolutionize the drug development process. It offers a comprehensive solution encompa...
Also comparing in this category
Comparing more than these two?
Get Deargen, Standigm and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Deargen compare?
A PDF of Deargen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Deargen with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Deargen on 15 Jun 2026, and Standigm on 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
